At AESGP, Challenges Temper Optimism As Leaders View Future Of OTC
This article was originally published in The Tan Sheet
Executive Summary
At the 45th annual meeting of the Association of the European Self-Medication Industry, executives reflected on the challenges of the European market even as OTC business units enjoy increased prominence within global and diversified organizations
You may also be interested in...
In Europe, Centralized OTC Switch Still Has A Few Bugs
The European Union's diversity means that when it comes to the new centralized procedure for Rx-to-OTC switches, there are several details yet to be ironed out, according to OTC industry executives
Nycomed Prepares To Launch First Nonprescription PPI With EU-Wide Approval
Nycomed is gearing up to launchPantozol Control (pantoprazole 20 mg) later this year when the firm expects an approval for European Union nonprescription marketing authorization
Pfizer To House Consumer, Nutritional Divisions In Diversified Businesses Unit
Pfizer will appoint Wyeth's consumer health president to manage its new Diversified Businesses group, which will include consumer, nutritional and animal health, as part of a reorganization following the companies' planned merger